Jump to Navigation

The FDA announced the 1997 withdrawal of Fenfluramine and Dexfenfluramine, also called "Phen-Fen" when used together. The FDA cited findings from doctors who have evaluated patients taking these two drugs with echocardiograms, devices that pick up echoes of the sound waves as they bounce off the heart. Approximately 30 percent of patients who were evaluated had abnormal echocardiograms, indicating significant risk associated with the drugs.

Dexfenfluramine, manufactured for Interneuron Pharmaceuticals, is marketed under the name of Redux. Fenfluramine, manufactured by American Home Products Corp., is marketed under the brand name Pondimin. The drugs were used clinically for the management of obesity, but women who took the drugs as diet aids off-label have also reported side effects. The FDA still receives reports of cardiac valvular disease in persons who have used Phen-Fen.

If you have suffered any heart problems and have used Phen-Fen, Fenfluramine or Dexfenfluramine, please obtain a Free Consultation by submitting our online form, or by calling 866-273-1941.

OFFICE LOCATION: 707 Grant Street, Suite 2500 | Pittsburgh, PA 15219 | Phone: 866-273-1941 | Fax: 412-281-4229 | Email Us | Get Directions